Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
CA 2228635 C · Owner: Korneluk, Robert G. · Inventors: Mackenzie, Alexander E.; Liston, Peter; Korneluk, Robert G.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; substantially pure polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primers and probes for the identification and isolation of additional IAP genes. In addition methods , for treating diseases and disorders involving apoptosis are provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 5, 1996 and granted November 26, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 5, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 5, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.